I
Overview
iHealth Labs makes home health devices like blood pressure monitors, glucose meters, ECG devices, pulse oximeters, and scales to help people track health at home. These devices send readings to a companion mobile app that displays current values and trends to support informed health decisions. The company differentiates itself by offering a wide range of at-home devices under a single ecosystem designed for consumers and chronic-condition management, aiming for affordability. Its goal is to empower people to manage their health more easily and share data with healthcare providers when needed.
Work here?Claim your company
Simplify's Take
What believers are saying
- December 2025 FDA clearance for Flu A&B/COVID-19/RSV broadens winter-testing revenue.
- Retail expansion into CVS, Walmart, Amazon, and independent pharmacies widened distribution in 2024.
- The AHA study on December 4, 2024 strengthened Unified Care's chronic-disease credibility.
What critics are saying
- Abbott, Roche, QuidelOrtho, and ACON crush commodity test margins by 2026.
- The 2026 workforce shrank to 311, and hiring cooled sharply to 13 roles.
- A future FDA adverse action on respiratory tests would quickly undermine iHealth's core revenue.
What makes iHealth Labs unique
- FDA-cleared multiplex respiratory tests plus home blood-pressure and glucose monitoring devices.
- Unified Care combines devices, coaching, and remote monitoring for hypertension and diabetes.
- Low-price consumer hardware, like iHealth Track at $39.99, drives mass-market reach.
Help us improve and share your feedback! Did you find this helpful?